Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04582825 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stroke-Card Registry

Study acronym: SCR
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Primary and study completion moved earlier from Jul 31, 2027 to Mar 31, 2027
    • Site details revised at 2 of 2 sites
    v9
  2. Site details revised at 1 of 2 sitesv8
  3. 2 versions Re-verified since Jun 20, 2022, no change to tracked fieldsv6-v7
  4. Study sites: 3 to 2
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Collaborators: 3 to 2
    v5
  5. Site details revised at 1 of 3 sitesv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2020 to Dec 9, 2020
    • Site details revised at 3 of 3 sites
    v3
  2. Start date: Oct 1, 2020 to Nov 1, 2020
    • Study description expanded, about 18 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
VASCage GmbH
8 trials monitored
See all monitored trials
Stroke
3,531 trials monitored
See 153 trials at risk
Stroke is the second leading cause of death and one of the main contributors to disability. Patients who survive the acute phase of ischemic stroke and those with transient ischemic attack (TIA) are at high risk of subsequent vascular events. Importantly, recurrent strokes are associated with a higher social and economic impact, higher case fatality, and worse clinical outcome than first-ever strokes. The burden of post-stroke complications, residual deficits, and inadequate medical and psychosocial care all contribute to long-term disability and reduced quality of life in these patients. The Department of Neurology of the Medical University Innsbruck undertook the STROKE-CARD trial (NCT02156778) between 2014 and 2018 with follow-up until 2019 to evaluate the efficacy of the Post-Stroke disease-management program STROKE-CARD care. After implementation of STROKE-CARD care, the investigators aim to document the quality of post-stroke care and compare outcome parameters to historical cohorts and the change over time. Furthermore the investigators aim to gain a large data-resource for future research of biomarkers, disease mechanisms, prognosis and imaging mechanisms for R\&D.
Trial Details
NCT Number NCT04582825
Lead Sponsor VASCage GmbH
Collaborators: Medical University Innsbruck, St John of God Hospital, Vienna
Conditions
(from sponsor)		 Ischemic Stroke, Transient Ischemic Attack
Related terms Ischemic Attack, Transient, Ischemic Stroke
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov